Though miR-421 has been identified to target multiple mRNAs to alter tumor progression, such as FOXO4 [15], MEF2D [26], and MTA1 [27], whether miR-421 can target PDE7B remains to be uncovered. The gene discussed is MTA1; the disease is neoplasm.